REGIOCIT is a Extracorporeal Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is Sodium Chloride; Sodium Citrate, Unspecified Form.
Product ID | 24571-123_34cf38df-f4f8-4776-8c2f-0c89dadc0f64 |
NDC | 24571-123 |
Product Type | Human Prescription Drug |
Proprietary Name | REGIOCIT |
Generic Name | Sodium Chloride, Sodium Citrate |
Dosage Form | Injection, Solution |
Route of Administration | EXTRACORPOREAL |
Marketing Start Date | 2020-09-18 |
Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
Labeler Name | Baxter Healthcare Corporation |
Substance Name | SODIUM CHLORIDE; SODIUM CITRATE, UNSPECIFIED FORM |
Active Ingredient Strength | 5 g/1000mL; g/1000mL |
Pharm Classes | Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2020-09-18 |
NDC Exclude Flag | N |
Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
REGIOCIT 87294070 5305295 Live/Registered |
GAMBRO LUNDIA AB 2017-01-09 |